Pioneering 4,11-Dioxo-4,11-dihydro-1<i>H</i>-anthra[2,3-<i>d</i>]imidazol-3-ium Compounds as Promising Survivin Inhibitors by Targeting ILF3/NF110 for Cancer Therapy-Reference-Cited by-同舟云学术

Pioneering 4,11-Dioxo-4,11-dihydro-1H-anthra[2,3-d]imidazol-3-ium Compounds as Promising Survivin Inhibitors by Targeting ILF3/NF110 for Cancer Therapy

Published:2023-12-11 Issue:24 Volume:66 Page:16843-16868
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Yuan Jing¹,Liu Zhanxiong²,Dong Yachun¹,Gao Feng²,Xia Xuelin²,Wang Penghui²,Luo Yanli³,Zhang Zhenfeng¹^ORCID,Yan Deyue²^ORCID,Zhang Wanbin¹²^ORCID

Affiliation:

1. Shanghai Key Laboratory for Molecular Engineering of Chiral Drugs, School of Pharmacy, Shanghai Jiao Tong University, 800 Dongchuan Road, Shanghai 200240, P. R. China

2. Frontiers Science Center for Transformative Molecules, School of Chemistry and Chemical Engineering, Shanghai Jiao Tong University, 800 Dongchuan Road, Shanghai 200240, P. R. China

3. Department of Pathology, Shanghai Sixth People’s Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200233, P. R. China

Funder

Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning

National Natural Science Foundation of China

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.3c01551

Reference65 articles.

1. Targeting survivin for therapeutic discovery: past, present, and future promises

2. Survivin Monomer Plays an Essential Role in Apoptosis Regulation

3. Small Molecule Survivin Inhibitor YM155 Displays Potent Activity Against Human Osteosarcoma Cells

4. Synthesis and biological evaluation of novel 2-arylvinyl-substituted naphtho[2,3- d ]imidazolium halide derivatives as potent antitumor agents

5. Survivin study: An update of “What is the next wave?”